The role of dialyzer biocompatibility in acute renal failure

Blood Purification

Volumn 18, Issue 1, 2000, Pages 1-12

  Vanholder, R ^a   De Vriese A ^a   Lameire, N ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CELLULOSE ACETATE; COMPLEMENT; CUPROPHANE; FREE RADICAL; POLY(METHYL METHACRYLATE); POLYACRYLONITRILE; POLYAMIDE; POLYSULFONE;

ACUTE KIDNEY FAILURE; BIOCOMPATIBILITY; COMPLEMENT ACTIVATION; DIALYSIS MEMBRANE; EDITORIAL; HEMODIALYSIS; HUMAN; KIDNEY FUNCTION; LEUKOCYTE ACTIVATION; PRIORITY JOURNAL;

EID: 0343920766     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000014402     Document Type: Editorial

References (126)

1. Stein JH, Lifschitz MD, Barnes LD: Current concepts on the patho-physiology of acute renal failure. Am J Physiol 1978:234:F171-F181.
2. Klausner JM, Paterson IS, Goldman G, et al: Postischemic renal injury is mediated by neutrophils and leukotrienes. Am J Physiol 1989; 256:F794-F802.
3. Thadhani R, Pascual M, Bonventre JV: Acute renal failure. N Engl J Med 1996;334:1448-1460.
4. Vanholder R, Lameire N, Hoste E, Van Loo A, Dhondt AM, Ringoir S: Different types of dialyzer membranes: Does the bio(in)compatibility matter in the treatment of ARF? Ren Fail 1996;18:471-479.
5. Canavese C, Stratta P, Vereellone A: The case for oxygen free radicals in the pathogenesis of ischemic acute renal failure. Nephron 1988;49: 9-15.
6. Hakim RM: Clinical implications of hemodialysis membrane biocompatibility. Kidney Int 1993;44:484-494.
7. Schiffl H, Lang SM, König A, Strasser T. Haider MC, Held E: Biocompatible membranes in acute renal failure: Prospective case-controlled study. Lancet 1994;344:570-572.
8. Schiffl H, Sitter T, Lang S, König A, Haider M, Held E: Bioincompatible membranes place patients with acute renal failure at increased risk of infection. ASAIO J 1995;41:M709-M712.
9. Hakim RM, Wingard RL, Parker RA: Effect of the dialysis membrane in the treatment of patients with acute renal failure. N Engl J Med 1994;331:1338-1342.
10. Van Loo AA, Vanholder RC, Bernaert PR, Vermassen FE, Van Der Vennet M, Lameire NH: Pretransplantation hemodialysis strategy influences early renal graft function. J Am Soc Nephrol 1998;9:473-481.
11. Himmelfarb J, Tolkoff-Rubin N, Chandran P, Parker RA, Wingard RL, Hakim R: A multicenter comparison of dialysis membranes in the treatment of acute renal failure requiring dialysis. J Am Soc Nephrol 1997;9:257-266.
12. Splendiani G, Mazzarella V: Letter to the editor. Artif Organs 1996;20:281.
13. Mehta R, MacDonald B, Gabbai F, Pahl M, Farkas A, Pascual M, Fowler W, ARF Collaborative Study Group: Effect of biocompatible membranes in the treatment of acute renal failure requiring dialysis (abstract). J Am Soc Nephrol 1996;7:1457.
14. Neveu H, Kleinknecht D, Brivet F, Loirat P, Landais P, The French Study Group on Acute Renal Failure: Prognostic factors in acute renal failure due to sepsis. Results of a prospective multicenter study. Nephrol Dial Transplant 1996;11:293-299.
15. Kurtal H, von Herrath D, Schaefer K: Is the choice of the membrane important for patients with acute renal failure requiring hemodialysis? Artif Organs 1995;19:391-394.
16. Cosentino F, Chaff C, Piedmonte M: Risk factors influencing survival in ICU acute renal failure. Nephrol Dial Transplant 1994; 9(suppl4):179-182.
17. Liano F, Pascual J, The Madrid Acute Renal Failure Study Group: Epidemiology of acute renal failure: A prospective, multicenter, community-based study. Kidney Int 1996;50:811-818.
18. Valeri A, Radhakrishnan J, Ryan R, Powell D: Biocompatible dialysis membranes and acute renal failure: A study in postoperative acute tubular necrosis in cadaveric renal transplant recipients. Clin Nephrol 1996;46:402-409.
19. Simpson K, Allison MEM: Dialysis and acute renal failure: Can mortality be improved? (abstract). Nephrol Dial Transplant 1993;8:946.
20. Gastaldello K, Melot C, Vanherweghem JL, Kahn RJ, Ticlemans C: Cellulose diacetate does as well as polysulfone for the treatment of acute renal failure in the intensive care unit (abstract). J Am Soc Nephrol 1996;7:1447.
21. Assouad M, Tseng S, Dunn K, Gonzalez J, Brennan S, Suki W: Biocompatibility of dialyzer membrane is important in the outcome of acute renal failure (abstract). J Am Soc Nephrol 1996;7:1447.
22. Mujais SK, Ivanovich P: Inconsequence of membrane choice in acute renal failure? Artif Organs 1996;20:454-455.
23. Kaplan AA: Haemodialysis membranes (letter). Lancet 1994;344:1362-1363.
24. Kaplan AA, Paganini EP, Bosch JP: Effect of the dialysis membrane in acute renal failure (letter). N Engl J Med 1995;332:961-962.
25. Shaldon S: Biocompatible membranes in acute renal failure (letter). Lancet 1996;347:205-206.
26. Schaefer K, von Herrath D: Acute renal failure and membranes. Some medical and ethical questions. Int J Artif Organs 1996;19:145-146.
27. Shaldon S: Biocompatible membranes in acute renal failure: Prospective case-controlled study (letter). Nephrol Dial Transplant 1997;12:235-236.
28. Jacobs C: Membrane biocompatibility in the treatment of acute renal failure: What is the evidence in 1996? Nephrol Dial Transplant 1997;12:38-42.
29. Boulton-Jones M: Dialysis membranes: Clinical effects. Lancet 1994;344:559.
30. Himmelfarb J, Hakim RM: The use of biocompatible dialysis membranes in acute renal failure. Adv Ren Repl Ther 1997;4(suppl 1):72-80.
31. Conger JD: Interventions in clinical acute renal failure: What are the data? Am J Kidney Dis 1995;26:565-576.
32. Lazarus JM, Owen WF: Role of bioincompatibility in dialysis morbidity and mortality. Am J Kidney Dis 1994;24:1019-10.32.
33. Locatelli F: Influence of membranes on morbidity. Nephrol Dial Transplant 1996; 11(suppl 2):116-120.
34. Alkhunaizi AM, Schrier RW: Management of acute renal failure: New perspectives. Am J Kidney Dis 1996;28:315-328.
35. Pascual M, Swinford RD, Tolkoff-Rubin N: Acute renal failure: Role of dialysis membrane biocompatibility. Annu Rev Med 1997;48: 467-476.
36. Schiffl H, Lang SM: Membranes in ARF: A Procrustean hypothesis or scientific advance? Int J Artif Organs 1997;20:359-365.
37. Vanholder R: Biocompatibility issues in hemodialysis. Clin Mat 1992;10:87-133.
38. Pascual M, Tolkoff-Rubin N, Schifferli J: Is adsorption an important characteristic of dialysis membranes? Kidney Int 1996;49:309-313.
39. Smeby LC, Wideroc TE, Balstad T, Jörstad S: Biocompatibility aspects of cellophane, cellulose acetate, polyacrylonitrile, polysulfone and polycarbonate hemodialyzers. Blood Purif 1986;4:93-101.
40. Levett DL, Woffindin C, Bird AG, Hoenieh NA, Ward MK, Kerr DNS: Complement activation in haemodialysis: A comparison of new and re-used dialysers. Int J Artif Organs 1986: 9:97-104.
41. Cheung AK, Parker CJ, Wilcox LA, Janatova J: Activation of complement by hemodialysis membranes: Polyacrylonitrile binds more C3a than cuprophan. Kidney Int 1990;37:1055-1059.
42. Paller MS: Hemoglobin-and myoglobin-in-duced acute renal failure in rat: Role of iron in nephrotoxicity. Am J Physiol 1988;255:F539-F544.
43. Paller MS: Renal work, glutathione and susceptibility to free radical-mediated postischemic injury. Kidney Int 1988;33:843-849.
44. Paller MS: Effect of neutrophil depletion on ischemic renal injury in the rat. J Lab Clin Med 1989;113:379-386.
45. Shaw SG, Weidmann P, Hodler J, Zimmermann A, Paternostro A: Atrial natriuretic peptide protects against acute ischemic renal failure in the rat. J Clin Invest 1987;80:1232-1237.
46. Walker PD, Shah SV: Evidence suggesting a role for hydroxyl radical in gentamycin-in-duced acute renal failure in rats. J Clin Invest 1988;81:334-341.
47. Gamelin LM, Zager RA: Evidence against oxidant injury as a critical mediator of postischemic acute renal failure. Am J Physiol 1988; 255:F450-F460.
48. 2 in postischemic injury of renal epithelial cells. Am J Physiol 1992;263:F251-F255.
49. Schulman G, Fogo A, Gung A, Badr K, Hakim R: Complement activation retards resolution of acute ischemic renal failure in the rat. Kidney Int 1991;40:1069-1074.
50. Rovin BH, Wurst E, Kohan DE: Production of reactive oxygen species by tubular epithelial cells in culture. Kidney hit 1990;37:1509-1514.
51. Stein JH, Osgood RW, Barnes JL, Reineck HJ, Pinckard RN, MacManus LM: The role of complement in the pathogenesis of postischemic renal failure. Miner Electrolyte Metab 1985;11:256-261.
52. Rossen RD, Michael LH, Hawkins HK, et al: Cardiolipin-protein complexes and initiation of complement activation after coronary occlusion. Circ Res 1994;75:546-555.
53. Birdsall HH, Green DM, Trial JA, et al: Complement C5a, TGF-β1, and MCP-1. in sequence, induce migration of monocytes into ischemic canine myocardium with n the first one to five hours after reperfusion. Circulation 1997;95:684-692.
54. Horstick G, Heimann A, Götze O, et al: Intracoronary application of C1 esterase inhibitor improves cardiac function and reduces myocardial necrosis in an experimental model of ischemia and reperfusion. Circulation 1997;95: 701-708.
55. Weiser MR, Williams JP, Moore FD, et al: Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement. J Exp Med 1996;183:2343-2348.
56. Hellberg POA, Källskog Ö, Wolgast M: Red cell trapping and postischemic renal blood flow. Differences between the cortex, outer and inner medulla. Kidney Int 1991;40:625-631.
57. Mason J, Torhorst J, Welsch J: Role of the medullary perfusion defect in the pathogenesis of ischemic renal failure. Kidney Int 1984;26: 283-293.
58. Solez K, Kramer EC, Fox JA, Heptanstall RH: Medullary plasma flow and intravascular leukocyte accumulation in acute renal failure. Kidney Int 1974;6:24-37.
59. Mason J, Welsch J, Torhorst J: The contribution of vascular obstruction to the functional defect that follows renal ischemia. Kidney Int 1987;31:65-71.
60. Hellberg POA, Källskog OT, Öjteg G, Wolgast M: Peritubular capillary permeability and intravascular RBC aggregation after ischemia: Effect of neutrophils. Am J Physiol 1990;258: F1018-F1025.
61. Espinosa G, Farré AL, Cernadas MR, et al: Role of endothelin in the pathophysiology of renal-ischemia reperfusion in normal rabbits. Kidney Int 1996;50:776-782.
62. Solez K, Morel-Maroger L, Sraer JD: The morphology of 'acute tubular necrosis' in man. Analysis of 57 renal biopsies and a comparison with the glycerol model. Medicine 1979;58: 362-376.
63. Kelly KJ, Williams WW, Colvin RB, Bonventre JV: Antibody to intracellular adhesion molecule 1 protects the kidney against ischemic injury. Proc Natl Acad Sci USA 1994;91:812-816.
64. Nguyen AT, Lethias C, Zingraff J, Herbelin A, Naret C, Descamps-Latscha B: Hemodialysis membrane-induced activation of phagocyte oxidative metabolism detected in vivo and in vitro with microamounts of whole blood. Kidney Int 1985;28:158-167.
65. Foreman KE, Glovsky MM, Warner RL, Horvath SJ, Ward PA: Comparative effect of C3a and C5a on adhesion molecule expression on neutrophils and endothelial cells. Inflammation 1996;20:1-9.
66. Ward PA: Role of complement, chemokines, and regulatory cytokines in acute lung injury. Ann NY Acad Sci 1996;796:104-112.
67. Linas SL, Whittenburg D, Parsons P, Repine JE: Mild renal ischemia activates primed neutrophils to cause acute renal failure. Kidney Int 1992;42:610-616.
68. De Backer WA, Verpooten GA, Borgonjon DJ, Vermeire PA, Lins RR, De Broe ME: Hypoxemia during dialysis: Effects of different membranes and dialysate compositions. Kidney Int 1983;23:738-743.
69. Vanholder RC, Pauwels RA, Vandenbogaerde JF, Lament HH, Van Der Straeten ME, Ringoir SM: Cuprophan reuse and intradialytic changes of lung diffusion capacity and blood gasses. Kidney Int 1987;32:117-122.
70. Vanholder R, Ringoir S, Dhondt A, Hakim R: Phagocytosis in uremic and hemodialysis patients: A prospective and cross-sectional study. Kidney Int 1991;39:320-327.
71. Dhondt AW, Vanholder RC, Waterloos MA, Glorieux GL, Ringoir SMG: Leukocyte CD14 and CD45 expression during hemodialysis: Polysulfone versus cuprophane. Nephron 1996; 74:342-348.
72. Davenport A, Davison AM, Will EJ: Are changes in intracranial pressure during intermittent machine haemofiltration dependent upon membrane biocompatibility? Int J Artif Organs 1989;12:703-707.
73. Cheung AK, Baranowski RL, Wayman AL: The role of thromboxane in cuprophane-induced pulmonary hypertension. Kidney Int 1987;32:1072-1079.
74. Vanholder R, De Smet R, Hsu C, Vogeleere P, Ringoir S: Uremic toxins: The middle molecule hypothesis revisited. Semin Nephrol 1994;14: 205-218.
75. Vanholder R, De Smet R, Waterloos MA, et al: Mechanisms of the uremic inhibition of phagocyte-reactive species production: Characterization of the role of p-cresol. Kidney Int 1995;47: 510-517.
76. Hörl WH, Haag-Weber M, Georgopoulos A, Block LH: Physicochemical characterization of a polypeptide present in uremic serum that inhibits the biological activity of polymorphonuclear cells. Proc Natl Acad Sci USA 1990;87: 6353-6357.
77. Kränzlin B, Gretz N, Kirschfink M, Mujais SK: Dialysis in rats with acute renal failure: Evaluation of three different dialyzer membranes. Artif Organs 1996;20:1162-1168.
78. Kränzlin B, Reuss A, Gretz N, Kirschfink M, Ryan CJ, Mujais SK: Recovery from ischemic acute renal failure: Independence from dialysis membrane type. Nephron 1996;73:644-651.
79. Michael UF, Logan JL, Meeks LA: The beneficial effects of thyroxine on nephrotoxic acute renal failure in the rat. J Am Soc Nephrol 1991; 1:1236-1240.
80. A receptor antagonist in the rat. J Clin Invest 1994;93: 900-906.
81. Luke DR, Vadici K, Lopex-Berestein G: Role of vascular congestion in cisplatin-induced acute renal failure in the rat. Nephrol Dial Transplant 1992;7:1-7.
82. Lin JJ, Cybulsky AV, Goodyer PR, Fine RN, Kaskel FJ: Insulin-like growth factor-1 enhances epidermal growth factor receptor activation and renal cell regeneration in postischemic acute renal failure. J Lab Clin Med 1995; 125:724-733.
83. Chan L, Chittinanandana A, Shapiro JI, Shanley PF, Schrier RW: Effect of an endothelin-receptor antagonist on ischemic acute renal failure. Am J Physiol 1994;266:F135-F138.
84. Fried TA, Hishida A, Barns JL, Stein JH: Ischemic acute renal failure in the rat: Protective effect of uninephrectomy. Am J Physiol 1984; 247:F568-F574.
85. Knaus WA, Draper EA, Wagner DP, Simmermann JE: APACHE II: A severity of disease classification system. Crit Care Med 1985;13: 818-829.
86. Bellomo R, Farmer M, Parkin G, Wright C, Boycc N: Severe acute renal failure: A comparison of acute continuous hemodiafiltration and conventional dialytic therapy. Nephron 1995; 71:59-64.
87. Bellomo R, Farmer M, Boyce N: The outcome of critically ill elderly patients with severe acute renal failure treated by continuous hemodiafiltration. Int J Artif Organs 1994;17:466-472.
88. Bellomo R, Parkin G, Love J, Boyce N: Use of continuous haemodiafiltration: An approach to the management of acute renal failure in the critically ill. Am J Nephrol 1992;12:240-245.
89. Bellomo R, Parkin G, Love J, Boyce N: A prospective comparative study of continuous arteriovenous hemodiafiltration and continuous venovenous hemodiafiltration in critically ill patients. Am J Kidney Dis 1993;21:400-404.
90. Bellomo R, Boyce N: Acute continuous hemodiafiltration: A prospective study of 110 patients and a review of the literature. Am J Kidney Dis 1993;21:508-518.
91. Bellomo R, Boyce N: Continuous venovenous hemodiafiltration compared with conventional dialysis in critically ill patients with acute renal failure. ASAIO J 1993;39:M794-M797.
92. Garlund B, Sjolin J, Nilsson A, Roll M, Wickerts CJ, Wretlind B: Plasma levels of cytokines in primary septic shock in humans: Correlation with disease severity. J Infect Dis 1995;172: 296-301.
93. Lortholary O, Fagon JY, Hoi AB, et al: Nosocomial acquisition of multiresistanl Acinetobacter baumannii: Risk factors and prognosis. Clin Infect Dis 1995;20:790-796.
94. Fink MP, Snydman DR, Niederman MS, et al: Treatment of severe pneumonia in hospitalized patients: Results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. Antimicrob Agents Chemother 1994;38:547-557.
95. Poses RM, MacClish DK, Smith WR, Bekes C, Scott WE: Prediction of survival of critically ill patients by admission comorbidity. J Clin Epidemiol 1996;49:743-747.
96. Stacpoole PW, Wright EC, Baumgartner TG, et al: Natural history and course of acquired lactic acidosis in adults. Am J Med 1994;97:47-54.
97. Pittet D, Monod M, Suter PM, Frenk E, Auckenthaler R: Candida colonization and subsequent infections in critically ill surgical paticnls. Ann Surg 1994;220:751-758.
98. Gomez-Jimenez J, Martin MC, Sauri R, et al: Interleukin-10 and the monocyte/macrophage-induced inflammatory response in septic shock. J Infect Dis 1995;171:472-475.
99. Kollef MH, Allen BT: Determinants of outcome for patients in the medical intensive care unit requiring abdominal surgery. Chest 1994;106:1822-1828.
100. Koperna T, Schulz F: Prognosis and treatment of peritonitis. Do we need new scoring systems? Arch Surg 1996;131:180-186.
101. McCarthy JT: Prognosis of patients with acute renal failure in the intensive-care unit: A table of two eras. Mayo Clin Proc 1996;71: 117-126.
102. Maher ER, Robinson KN, Scoble JE, et al: Prognosis of critically-ill patients with acute renal failure: APACHE II score and other predictive factors. Q J Med 1989;72:857-866.
103. Brivel FG, Kleinknecht DJ, Loirat P, Landais PJM, The French Study Group on Acute Renal Failure: Acute renal failure in intensive care units - Causes, outcome, and prognostic factors of hospital mortality: A prospective, multicenter study. Crit Care Med 1996;24: 192-198.
104. Mujais S, Ivanovich P: Haemodialysis membranes (letter). Lancet 1994;344:1362-1362.
105. Schiffl H, Lang SM: Biocompatible membranes in acute renal failure (letter). Lancet 1996;347:205-206.
106. Vanholder R, Van Biesen W, Ringoir S: Contributing factors to the inhibition of phagocytosis in hemodialyzed patients. Kidney Int 1993;44:208-214.
107. Schiffl H, Strasser Th: Dialysis membrane, inflammatory mediators, and resolution of acute renal failure (abstract). Artif Organs 1993;17:459.
108. Schiffl H, Sitter T, Lang S: Hemodialysis in acute renal failure: Which type of dialysis membrane? In Vincent JL (ed): Yearbook of Intensive Care and Emergency Medicine. Stuttgart, Springer 1995, pp 757-763.
109. Schiffl H, Sitter T, Lang S, König A, Held E: Effect of the dialysis membrane on mortality rate in patients with acute renal failure (abstract). Artif Organs 1995;10:1037.
110. Boldt J, Wollbrück M, Kuhn D, Linke C, Hempelmann G: Do plasma levels of circulating soluble adhesion molecules differ between surviving and nonsurviving critically ill patients? Chest 1995;107:787-792.
111. Knaus WA, Wagner DP: Multiple systems organ failure: Epidemiology and prognosis. Crit Care Clin 1989;5:221-232.
112. Cioffi WG, Ashikaga T, Gamelli RL: Probability of surviving postoperative acute renal failure. Ann Surg 1984;200:205-211.
113. Lien J, Chan V: Risk factors influencing survival in acute renal failure treated by hemodialysis. Arch Intern Med 1985;145:2067-2069.
114. Schaefer JH, Jochimsen F, Keller F, Wegschneider K, Distler A: Outcome prediction of acute renal failure in medical intensive care. Intensive Care Med 1991;17:19-24.
115. Spiegel DM, Ullian ME, Zerbe GO, Berl T: Determinants of survival and recovery in acute renal failure patients dialyzed in intensive-care units. Am J Nephrol 1991;11:44-47.
116. Groeneveld ABJ, Tran DD, Van Der Meulen J, Neuta JJP, Thijs LG: Acute renal failure in the medical intensive care unit: Predisposing, complicating factors and outcome. Nephron 1991;59:602-610.
117. Woodrow G, Turney JH: Cause of death in acute renal failure. Nephrol Dial Transplant 1992;7:230-234.
118. Spurney RF, Fulkerson WJ, Schwab SJ: Acute renal failure in critically ill patients: Prognosis for recovery of kidney function after prolonged dialysis support. Crit Care Med 1991;19:8-11.
119. Lameire N, Matthys E, Vanholder R, et al: Causes and prognosis of acute renal failure in elderly patients. Nephrol Dial Transplant 1987;2:316-322.
120. Haag-Weher M, Mai B, Deppisch R, Göhl H, Hörl WH: Studies of biocompatibility of different dialyzer membranes: Role of complement system, intracellular calcium and inisitol-triphosphate. Clin Nephrol 1994;41:245-251.
121. Von Herrath D, Huiler M, Hartenstein-Koch K, Kutschera D, Schaefer K, Dati F: Good biocompatibility of the polyamide hemofilter. Blood Purif 1988;6:106-110.
122. Skroeder NR, Jacobson SH, Lins LE, Kjellstrand CM: Acute symptoms during and between hemodialysis: The relative role of speed, duration, and biocompatibility of dialysis. Artif Organs 1994;18:880-887.
123. Skroeder NR, Kjellstrand P, Holmquist B, Kjellstrand CM, Jacobson SH: Individual differences in biocompatibility responses to hemodialysis. Int J Artif Organs 1994;17:521-530.
124. Dameche L, Brunet P, George F, et al: Meltspun cellulose diacetate and polysulfone membranes have the same effect on complement activation and expression of leukocyte adhesion molecules and complement receptors. Nephrol Dial Transplant 1995; 10(suppl 10):33-38.
125. Jörres A, Dobis C, Gahl GM, et al: Hemodialysis membrane biocompatibility does not impact on the mortality of patients with acute renal failure: A prospective randomized international multicenter trial (abstract). J Am Soc Nephrol 1998;9:212-213.
126. Mehta R, McDonald B, Gabbai F, Pahl M, Farkas A, Pascual M, Fowler W, ARF Collaborative Study Group: Hemodialysis membrane biocompatibility does not impact on the mortality of patients with acute renal failure: A prospective randomized international multicenter trial (abstract). J Am Soc Nephrol 1996;7:1457.